Dramatic, Durable Hair Growth With Oral JAK Inhibitor Oral baricitinib superior to placebo at 36 weeks in BRAVE-AA1 and BRAVE-AA2 trials Mar 27, 2022
Make the Diagnosis: More Than a Cosmetic Problem? A 20-year-old man went to the doctor after noticing multiple cystic lesions that recently appeared on his trunk. Mar 24, 2022
Autoimmunity and No COVID Vax? It's Not All Bad News Some risk but also some benefit seen with biologic therapies Mar 24, 2022
Novel Fixed-Dose Immunotherapy Combo Wins FDA Approval Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer Nodal metastasis detected more often than by clinical exam, worrisome false-positive rate Mar 18, 2022
Clinic-Based Hidradenitis Suppurativa Surgery Gets High Marks From Patients High satisfaction after three-fourths of procedures, despite frequent recurrences Mar 17, 2022
Extension Study Confirms JAK Inhibitor's Activity in Atopic Dermatitis EASI75 response rate exceeding 80% through 52 weeks of upadacitinib treatment Mar 16, 2022
FDA Warns on Using Surgical Device for Aesthetic Skin Procedures Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
Make the Diagnosis: Is This a Manifestation of Her Crohn’s Disease? A 55-year-old woman presents to the doctor with a vesicular and pustular rash that appeared on her arm in a dermatomal distribution. Mar 10, 2022
Gauging Cardiovascular Risk in Psoriatic Disease: It's Complicated Framingham scores may not tell the whole story Mar 09, 2022
Novel Therapies Active in Head and Neck Cancers High response rate with oncolytic virus plus immunotherapy in cutaneous lesions Feb 28, 2022
AAD Drops Vaccine Requirement for Annual Meeting Society says the move follows host city Boston's recent change in policy Feb 24, 2022
Make the Diagnosis: Is This Something To Worry About? At his 6-year-old daughter's regular check-up, a father asked the pediatrician to look at a skin condition that had recently developed on his daughter's abdomen. Feb 24, 2022
Merkel Cell Carcinoma Much More Likely to Recur vs Other Skin Cancers 5-year recurrence rate was 40% compared with 19% for melanoma Feb 23, 2022
Predicting Treatment Response in Inflammatory Muscle Disorders Swedish registry study elicits factors associated with improvement Feb 16, 2022
Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis Clinicians consider many differentials Feb 14, 2022
Make the Diagnosis: More Than an Itch A 66-year-old man went to the doctor after experiencing an extremely itchy rash for the preceding 2 months. Feb 10, 2022
Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
Hair Loss Drugs Ranked in Order of Efficacy Meta-analysis attempts a head-to-head comparison Feb 07, 2022
Evidence Begins to Gel for Atopic Dermatitis, Multiple Comorbid Conditions Atopic, metabolic, cardiovascular, and mental health conditions cited in guideline update Feb 02, 2022
Six Medical Specialties With the Highest Hourly Wages Plastic and orthopedic surgery top the list Jan 27, 2022
Time's Up for Anti-PD-1/L1 Plus Targeted Therapy in BRAF Melanoma Third trial testing the approach shows no significant PFS improvement Jan 26, 2022
Psoriasis Patients, Docs Want to Do More to Prevent Heart Problems Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitis Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
Make the Diagnosis: Why Did These Multicolored, Painful Plaques Appear on Her Legs? A 60-year-old woman went to the doctor after noticing sudden onset of extremely painful, dark areas that had developed on her legs over the course of a few days. Jan 18, 2022
Active Surveillance for Melanoma Meets Reality of Loss to Follow-Up More than a third of patients lost to follow-up in "real-world" experience Jan 10, 2022
Melanoma Patient on Immunotherapy Develops Severe Dermatitis Clinicians faced with presumed dermatologic AEs urged to consider all differentials Jan 10, 2022
South Africa's Four COVID Waves; A New Prostate Cancer Treatment Combo Also in TTHealthWatch: anticoagulants and respiratory infections, and treating advanced melanoma Jan 08, 2022 podcast
IL-13 Inhibitor Approved for Adults With Atopic Dermatitis Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor Complete clearance of pustules in half of patients in 1 week with spesolimab Dec 23, 2021
Doc Fired After Standing Up to Private Equity; RFK Jr.'s Anti-Vax Machine This past week in healthcare investigations Dec 22, 2021
Make the Diagnosis: Truncal Eruption in a Transgender Man A 17-year-old transgender man visited his doctor reporting fever, multiple joint pain, and a progressive truncal eruption that had begun a few weeks prior. Dec 17, 2021
J&J Shot Faces New Scrutiny; Relaxed Rules for Abortion Pill? New PsA Drug OK'd A daily roundup of news on COVID-19 and the rest of medicine Dec 16, 2021
Long-Term Data Reinforce Standard of Care in Unresectable Melanoma Landmark trial shows median OS of 72.1 months with nivolumab-ipilimumab Dec 01, 2021
Think TikTok Is Smarter Than Me? Then I'm Not the Right Doctor for You Modern times have fundamentally altered the landscape of healthcare Nov 30, 2021
Immunotherapy Combo Produces Durable Responses in Melanoma Brain Metastases More than half of patients responded to nivolumab-ipilimumab, 72% alive at 3 years Nov 18, 2021
Does Immunotherapy Late in the Day Affect Survival in Melanoma? Better outcomes when at least 80% of infusions were given earlier in the day, study found Nov 17, 2021
Immunotherapy First Wins in Advanced BRAF-Positive Melanoma DREAMseq shows 20% absolute improvement in 2-year survival with nivolumab-ipilimumab upfront Nov 15, 2021
Signs of Relief From 'Therapeutic Drought' in Atopic Dermatitis Encouraging results from pipeline agents targeting Th2-specific inflammation Nov 09, 2021
Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021